A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid

Medical Mycology

Volumn 45, Issue 2, 2007, Pages 143-148

  Hu, Weimin ^a   Ninomiya, Kentaro ^a   Ishibashi, Hiroko ^a   Maruyama, Naho ^a   Oshima, Haruyuki ^a   Yamaguchi, Hideyo ^a   Abe, Shigeru ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Antifungal; Asthma; COPD; HIV; Inflammation; Steroid inhaler

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FUNGAL CELL; HISTOPATHOLOGY; MOUSE; NONHUMAN; OROPHARYNX CANDIDIASIS; THRUSH;

ADMINISTRATION, INHALATION; ANIMALS; ANTIFUNGAL AGENTS; BECLOMETHASONE; CANDIDA ALBICANS; CANDIDIASIS, ORAL; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; FLUCONAZOLE; HISTOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED ICR; PHARYNX;

CANDIDA; MURINAE;

EID: 33847710198     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780601103098     Document Type: Article

References (21)

1. Donohue, JF and Ohar, JA. (2004) Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc, 3, pp. 152-160.
2. Roland, NJ, Bhalla, RK and Earis, J. (2004) The local side effects of inhaled corticosteroids: Current understanding and review of the literature. Chest, 126, pp. 213-219.
3. Ellepola, ANB and Samaranayake, LP. (2001) Inhalational and topical steroids and oral candidiasis: A mini review. Oral Dis, 7, pp. 211-216.
4. Jackson, LD, Polygenis, D. and Mcivor, RA. (1999) Comparative efficacy and safety of inhaled corticosteroids in asthma. Can J Clin Pharmacol, 6, pp. 26-37.
5. Kuna, P. (1998) Long-term effects of steroid therapy. Wiad Lek, 51, pp. 12-18.
6. Lipworth, BJ. (1993) Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther, 58, pp. 173-209.
7. Samaranayake, LP and Holmstrup, P. (1989) Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med, 18, pp. 554-564.
8. Spector, SL, Wangaard, C. and Bardana Jr, EJ (1982) The use of cultures and immunologic procedures to predict oropharyngeal candidiasis in patients on steroid aerosols. Clin Allergy, 12, pp. 269-278.
9. Willey, RF, Milne, LJ, Crompton, GK and Grant, IW. (1976) Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest, 70, pp. 32-38.
10. Milne, LJ and Crompton, GK. (1974) Beclomethasone dipropionate and oropharyngeal candidiasis. Br Med J, 3, pp. 797-798.
11. Vogt, FC. (1979) The incidence of oral candidiasis with the use of inhaled corticosteroids. Ann Allergy, 43, pp. 205-210.
12. Salzman, GA and Pyszczynski, DR. (1988) Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered dose inhaler alone and with Aerochamber. J Allergy Clin Immunol, 81, pp. 424-428.
13. Toogood, JH. (1990) Complications of topical steroid therapy for asthma. Am Rev Respir Dis, 141, pp. S89-S96.
14. Klein, RS, Carol, AH and Small, CB (1984) Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Eng J Med, 311, pp. 354-358.
15. Sangeorzan, JA and Bradley, SF (1994) Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med, 97, pp. 339-346.
16. Chakir, J., Cote, L., Coulombe, C. and Deslauriers, N. (1994) Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol Immunol, 9, pp. 88-94.
17. Elahi, S., Pang, G., Clancy, R. and Ashman, RB. (2000) Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun, 68, pp. 5771-5777.
18. Samaranayake, YH and Samaranayake, LP. (2001) Experimental oral candidiasis in animal models. Clin Microbiol Rev, 14, pp. 398-429.
19. Walsh, TJ, Gonzalez, CE and Piscitelli, S. (2000) Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. J Clin Microbiol, 38, pp. 2369-2373.
20. Takakura, N., Sato, Y. and Ishibashi, H. (2003) A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol, 47, pp. 321-326.
21. Maebashi, K., Itoyama, T., Uchida, K., Suegara, N. and Yamaguchi, H. (1994) A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs. J Med Vet Mycol, 32, pp. 349-359.